In this episode of MAC: Behind the Trials, we ask: How can metabolomics shape the future of clinical research?
Metabolomics, the large-scale study of metabolites in the body — offers new possibilities for understanding disease, identifying biomarkers, and designing more predictive clinical trials.
Dr Scott Harrison, Director of Laboratory Services at MAC Clinical Research, shares how this emerging field could accelerate personalised medicine, improve patient stratification, and reduce uncertainty in drug development.
Join us as we explore the role metabolomics may play in the next generation of clinical trials, and what it means for the future of research and treatment.
